Prolonged survival as a component of hereditary breast and nonpolyposis colon cancer

Henry T. Lynch, William Albano, James Recerbaren, Patrick M. Lynch, Jane F. Lynch, Robert Elston

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Identification of prolonged survival in hereditary breast and colon cancer (exclusive of familial multiple adenomatous polyposis coli) have been shown to be statistically significant (P <.05) when compared to the American College of Surgeons Tumor Registry for these respective neoplasms. Our hypothesis is that the genotype in hereditary cancer determines both susceptibility and natural history, such that increased survival is a manifestation of the natural history.

Original languageEnglish
Pages (from-to)1201-1209
Number of pages9
JournalMedical Hypotheses
Volume7
Issue number9
DOIs
StatePublished - 1981

Fingerprint

Hereditary Nonpolyposis Colorectal Neoplasms
Adenomatous Polyposis Coli
Breast
Natural History
Neoplasms
Colonic Neoplasms
Registries
Genotype
Breast Neoplasms

All Science Journal Classification (ASJC) codes

  • Developmental Biology
  • Medicine(all)
  • Drug Discovery

Cite this

Prolonged survival as a component of hereditary breast and nonpolyposis colon cancer. / Lynch, Henry T.; Albano, William; Recerbaren, James; Lynch, Patrick M.; Lynch, Jane F.; Elston, Robert.

In: Medical Hypotheses, Vol. 7, No. 9, 1981, p. 1201-1209.

Research output: Contribution to journalArticle

Lynch, Henry T. ; Albano, William ; Recerbaren, James ; Lynch, Patrick M. ; Lynch, Jane F. ; Elston, Robert. / Prolonged survival as a component of hereditary breast and nonpolyposis colon cancer. In: Medical Hypotheses. 1981 ; Vol. 7, No. 9. pp. 1201-1209.
@article{fafd0ef93f7548d98c4e492f4de7f288,
title = "Prolonged survival as a component of hereditary breast and nonpolyposis colon cancer",
abstract = "Identification of prolonged survival in hereditary breast and colon cancer (exclusive of familial multiple adenomatous polyposis coli) have been shown to be statistically significant (P <.05) when compared to the American College of Surgeons Tumor Registry for these respective neoplasms. Our hypothesis is that the genotype in hereditary cancer determines both susceptibility and natural history, such that increased survival is a manifestation of the natural history.",
author = "Lynch, {Henry T.} and William Albano and James Recerbaren and Lynch, {Patrick M.} and Lynch, {Jane F.} and Robert Elston",
year = "1981",
doi = "10.1016/0306-9877(81)90063-3",
language = "English",
volume = "7",
pages = "1201--1209",
journal = "Medical Hypotheses",
issn = "0306-9877",
publisher = "Churchill Livingstone",
number = "9",

}

TY - JOUR

T1 - Prolonged survival as a component of hereditary breast and nonpolyposis colon cancer

AU - Lynch, Henry T.

AU - Albano, William

AU - Recerbaren, James

AU - Lynch, Patrick M.

AU - Lynch, Jane F.

AU - Elston, Robert

PY - 1981

Y1 - 1981

N2 - Identification of prolonged survival in hereditary breast and colon cancer (exclusive of familial multiple adenomatous polyposis coli) have been shown to be statistically significant (P <.05) when compared to the American College of Surgeons Tumor Registry for these respective neoplasms. Our hypothesis is that the genotype in hereditary cancer determines both susceptibility and natural history, such that increased survival is a manifestation of the natural history.

AB - Identification of prolonged survival in hereditary breast and colon cancer (exclusive of familial multiple adenomatous polyposis coli) have been shown to be statistically significant (P <.05) when compared to the American College of Surgeons Tumor Registry for these respective neoplasms. Our hypothesis is that the genotype in hereditary cancer determines both susceptibility and natural history, such that increased survival is a manifestation of the natural history.

UR - http://www.scopus.com/inward/record.url?scp=0019812435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019812435&partnerID=8YFLogxK

U2 - 10.1016/0306-9877(81)90063-3

DO - 10.1016/0306-9877(81)90063-3

M3 - Article

VL - 7

SP - 1201

EP - 1209

JO - Medical Hypotheses

JF - Medical Hypotheses

SN - 0306-9877

IS - 9

ER -